Loss of asthma control and activation of coagulation and fibrinolysis

Clinical and Experimental Allergy

Volumn 46, Issue 3, 2016, Pages 422-427

  Sneeboer, M M S ^a   Fens, N ^a   van de Pol, M A ^a   Majoor, C J ^a   Meijers, J C M ^a,b   Kamphuisen, P W ^c   Lutter, R ^a   Sterk, P J ^a   Bel, E H D ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Asthma; Coagulation; Fibrinolysis; Haemostasis; Loss of control

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; D DIMER; FLUTICASONE; STEROID; VON WILLEBRAND FACTOR; ANTIASTHMATIC AGENT; BIOLOGICAL MARKER; NITRIC OXIDE;

ADULT; ARTICLE; ASTHMA; ATOPY; BLOOD CLOTTING; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; FIBRINOLYSIS; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; STEROID THERAPY; TREATMENT WITHDRAWAL; VIRUS INFECTION; ADOLESCENT; BLOOD; DISEASE COURSE; LEUKOCYTE COUNT; METABOLISM; PATHOPHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOMARKERS; BLOOD COAGULATION; DISEASE PROGRESSION; FEMALE; FIBRINOLYSIS; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOCYTE COUNT; MALE; NITRIC OXIDE; RISK FACTORS; YOUNG ADULT;

EID: 84959053505     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12667     Document Type: Article

References (30)

1. Green RH, Brightling CE, McKenna S et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360:1715-21.
2. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005; 131:417-30.
3. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med 2010; 38:S26-S34.
4. de Boer JD, Majoor CJ, van't Veer C, Bel EH, van der Poll T. Asthma and coagulation. Blood 2012; 119:3236-44.
5. Brims FJ, Chauhan AJ, Higgins B, Shute JK. Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids. Thorax 2009; 64:1037-43.
6. Kanazawa H, Yoshikawa T. Up-regulation of thrombin activity induced by vascular endothelial growth factor in asthmatic airways. Chest 2007; 132:1169-74.
7. Gabazza EC, Taguchi O, Tamaki S et al. Thrombin in the airways of asthmatic patients. Lung 1999; 177:253-62.
8. Ma Z, Paek D, Oh CK. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation. Clin Exp Allergy 2009; 39:1136-44.
9. Kowal K, Bodzenta-Lukaszyk A, Pampuch A, Szmitkowski M, Donati MB, Iacoviello L. Plasminogen activator inhibitor-1 plasma concentration in allergic asthma patients during allergen challenge. Int Arch Allergy Immunol 2007; 144:240-46.
10. Tutluoglu B, Gurel CB, Ozdas SB et al. Platelet function and fibrinolytic activity in patients with bronchial asthma. Clin Appl Thromb Hemost 2005; 11:77-81.
11. Majoor CJ, Kamphuisen PW, Zwinderman AH et al. Risk of deep-vein thrombosis and pulmonary embolism in asthma. Eur Respir J 2013; 42:655-61.
12. Chung WS, Lin CL, Ho FM et al. Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study. Eur Respir J 2014; 43:801-07.
13. Global Initiative for Asthma, Global strategy for asthma management and prevention 2002, http://www.ginasthma.org/local/uploads/files/GINAwr02.pdf (Last accessed 26 August 2015).
14. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000; 161:64-72.
15. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14:902-07.
16. Miller MR, Hankinson J, Brusasco V et al. Standardisation of spirometry. Eur Respir J 2005; 26:319-38.
17. American Thoracic Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171:912-30.
18. Belda J, Parameswaran K, Lemiere C, Kamada D, O'Byrne PM, Hargreave FE. Predictors of loss of asthma control induced by corticosteroid withdrawal. Can Respir J 2006; 13:129-33.
19. Undas A, Ciesla-Dul M, Drazkiewicz T, Potaczek DP, Sadowski J. Association between atopic diseases and venous thromboembolism: a case-control study in patients aged 45 years or less. J Thromb Haemost 2011; 9:870-3.
20. Potaczek DP. Links between allergy and cardiovascular or hemostatic system. Int J Cardiol 2014; 170:278-85.
21. Pampuch A, Kowal K, Bodzenta-Lukaszyk A et al. The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients. Allergy 2006; 61:234-38.
22. Kasperska-Zajac A, Rogala B. Platelet activation during allergic inflammation. Inflammation 2007; 30:161-6.
23. Page C, Pitchford S. Platelets and allergic inflammation. Clin Exp Allergy 2014; 44:901-13.
24. Kowal K, Pampuch A, Kowal-Bielecka O, DuBuske LM, Bodzenta-Lukaszyk A. Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus. Clin Exp Allergy 2006; 36:426-32.
25. Keller TT, van Wissen M, Mairuhu AT, van Doornum GJ, Brandjes DP. Acute respiratory tract infections in elderly patients increase systemic levels of hemostatic proteins. J Thromb Haemost 2007; 5:1567-69.
26. van Wissen M, Keller TT, van Gorp EC et al. Acute respiratory tract infection leads to procoagulant changes in human subjects. J Thromb Haemost 2011; 9:1432-34.
27. Le VB, Schneider JG, Boergeling Y et al. Platelet Activation and Aggregation Promote Lung Inflammation and Influenza Virus Pathogenesis. Am J Respir Crit Care Med 2015; 191:804-19.
28. Cho SH, Hong SJ, Chen H et al. Plasminogen activator inhibitor-1 in sputum and nasal lavage fluids increases in asthmatic patients during common colds. J Allergy Clin Immunol 2014; 133:1465-7, 67.e1-2.
29. Majoor CJ, van de Pol MA, Kamphuisen PW et al. Evaluation of coagulation activation after Rhinovirus infection in patients with asthma and healthy control subjects: an observational study. Respir Res 2014; 15:14.
30. Middeldorp S, Meijers JC, van den Ende AE et al. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study. Thromb Haemost 2000; 84:4-8.